Abstract
There are numerous lines of evidence pointing to norepinephrine being of crucial importance in pathophysiology of anxiety and mood disorders. First, norepinephrine projections innervate the limbic system, suggesting the involvement of norepinephrine in the regulation of emotions and cognition. Second, norepinephrine closely interacts with serotonin and dopamine systems, which also play very important roles in the regulation of mood. Third, it has been shown that various agents which increase norepinephrine availability, such as norepinephrine reuptake inhibitors, are also effective antidepressant drugs. And fourth, the depletion of norepinephrine causes a resurgence of depressive symptoms after successful treatment with noradrenergic antidepressant drugs. These observations suggest that the intensification of norepinephrine transmission can be beneficial in the treatment of affective disorders. However, various psychotropic medications have indirect effect on norepinephrine transmission. This review examines the effects of psychiatric medications on the norepinephrine system and proposes how they might be used to improve treatment outcome.
Current Drug Targets
Title: Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications
Volume: 10 Issue: 11
Author(s): Eliyahu Dremencov, Mostafa el Mansari and Pierre Blier
Affiliation:
Abstract: There are numerous lines of evidence pointing to norepinephrine being of crucial importance in pathophysiology of anxiety and mood disorders. First, norepinephrine projections innervate the limbic system, suggesting the involvement of norepinephrine in the regulation of emotions and cognition. Second, norepinephrine closely interacts with serotonin and dopamine systems, which also play very important roles in the regulation of mood. Third, it has been shown that various agents which increase norepinephrine availability, such as norepinephrine reuptake inhibitors, are also effective antidepressant drugs. And fourth, the depletion of norepinephrine causes a resurgence of depressive symptoms after successful treatment with noradrenergic antidepressant drugs. These observations suggest that the intensification of norepinephrine transmission can be beneficial in the treatment of affective disorders. However, various psychotropic medications have indirect effect on norepinephrine transmission. This review examines the effects of psychiatric medications on the norepinephrine system and proposes how they might be used to improve treatment outcome.
Export Options
About this article
Cite this article as:
Dremencov Eliyahu, Mansari el Mostafa and Blier Pierre, Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications, Current Drug Targets 2009; 10 (11) . https://dx.doi.org/10.2174/138945009789735165
DOI https://dx.doi.org/10.2174/138945009789735165 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Guinea Pig as an Animal Model for Asthma
Current Drug Targets Challenges in Diagnosing Cerebral Lacunar Infarcts
Current Medical Imaging From Mice to Macaques – Animal Models of HIV Nervous System Disease
Current HIV Research β-Lactams as Neuroprotective Agents
Anti-Infective Agents in Medicinal Chemistry Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Substance P Regulation in Epilepsy
Current Neuropharmacology An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors
Current Pharmaceutical Design Sulfur Dioxide: a Novel Gaseous Signal in the Regulation of Cardiovascular Functions
Mini-Reviews in Medicinal Chemistry Kynurenines in the Central Nervous System: Recent Developments
Central Nervous System Agents in Medicinal Chemistry Substance-Induced Psychoses: A Critical Review of the Literature
Current Drug Abuse Reviews Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System
Current Protein & Peptide Science Chronobiology of the Neuroimmunoendocrine System and Aging
Current Pharmaceutical Design Impulse Control Disorders in Parkinson’s Disease: A Review
Current Psychiatry Reviews Neuronal Histamine and its Receptors in Obesity and Diabetes
Current Diabetes Reviews MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Current Medicinal Chemistry - Central Nervous System Agents Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Methodological Considerations to Understand the Sensory Function of TRP Channels
Current Pharmaceutical Biotechnology Imaging Endogenous Neurotransmitters In Vivo with Positron Emission Tomography Displacement Studies
Current Psychopharmacology Overview and Findings from the Rush Memory and Aging Project
Current Alzheimer Research